4//SEC Filing
Owen Catherine E. 4
Accession 0001439222-23-000089
CIK 0001439222other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:32 PM ET
Size
7.8 KB
Accession
0001439222-23-000089
Insider Transaction Report
Form 4
Owen Adams Catherine
Director
Transactions
- Award
Stock options (right to buy)
2023-06-13+33,177→ 33,177 totalExercise: $26.56Exp: 2033-06-13→ Common stock (33,177 underlying) - Award
Restricted stock units
2023-06-13+5,929→ 5,929 total→ Common stock (5,929 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
- [F3]This option was granted on June 13, 2023. The shares underlying this option vest as to 25% of the underlying shares on June 13, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001816838
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:32 PM ET
- Size
- 7.8 KB